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Abstract 
Invasive fungal diseases remain nowadays life-threatening conditions affecting multiple clinical 
settings. The onset of these diseases is dependent on numerous factors, of which the 
“immunocompromised” phenotype of the patients is the more often acknowledged. However, 
and despite comparable immune dysfunction, not all patients are ultimately susceptible to 
disease, suggesting that additional risk factors, likely of genetic nature, may also be important. In 
the last years, genetic variants in several immune-related genes have also been proposed as 
major determinants of the susceptibility pattern of high-risk patients to invasive fungal diseases. 
Altogether, these findings highlighted the crucial significance of the individual genetic make-up 
in defining susceptibility to infection, providing a compelling rationale for the introduction of the 
immunogenetic profile as a risk prediction measure that may ultimately help to guide clinicians 
in the use of prophylaxis and preemptive fungal therapy in high-risk patients. 
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Introduction 
Fungal diseases are epidemiologically characteristic of high-risk groups. These include patients 
with hematological malignancies, prolonged and severe neutropenia, undergoing corticosteroid 
therapy or submitted to solid organ or stem cell transplantation, among others. However, 
besides the relative risk conferred by the “immunocompromised” phenotype as a result of the 
underlying condition or treatment scheme, certain individuals with specific, genetically-
determined, immune defects are also more vulnerable to infection. 
Over the last decades, considerable advances have been made in understanding the 
molecular bases determining disparate susceptibilities to infectious diseases in humans. 
Monogenetic defects underlying primary immunodeficiencies (PIDs) have been classically 
associated with predisposition to a restricted spectrum of fungal pathogens causing clinically 
defined manifestations. For example, the hyper-IgE syndrome (HIES) or the autoimmune 
polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome are usually 
correlated with susceptibility to superficial fungal infections, most remarkably chronic 
mucocutaneous candidiasis (CMC). On the other hand, chronic granulomatous disease (CGD), an 
inherited disorder of the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase complex that impairs the production of reactive oxygen species, predisposes to several 
recurrent life-threatening infections, of which invasive aspergillosis (IA) is the most distinctive 
fungal disease. 
In addition to PIDs, other factors modifying risk of fungal disease are often genetic 
polymorphisms. These have a substantial allele prevalence in the general population but, under 
select contexts of immunocompromise typical of many clinical settings, may translate into a 
further severity of the immunological dysfunction, ultimately rendering these individuals more 
prone to disease. In this article, we review the contribution of genetic polymorphisms of the 
immune system to susceptibility to invasive fungal diseases and discuss how this knowledge 
may be used for the design of individually tailored approaches to be integrated in clinical 
practice. 
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Genetic defects of PRRs and susceptibility to invasive fungal diseases 
Invasive fungal diseases are usually devastating conditions associated with high mortality rates 
and that affect a broad range of patients with apparently disparate underlying risk factors (e.g. 
allogeneic stem cell transplant recipients). Given the need to predict risk for disease in these 
patients and design effective preventive strategies, a relatively large number of studies have 
investigated the association between genetic variants of pattern recognition receptors (PRRs) or 
inflammatory mediators and risk of invasive fungal diseases (Carvalho et al., 2010b) (Figure 1). 
 
Toll-like receptors (TLRs) 
TLRs participate in the recognition of microbial structures and in the initiation of inflammatory 
and antimicrobial host defenses. They are expressed in several cell types including, but not 
exclusively, monocytes, macrophages, dendritic cells and neutrophils, and can be predominantly 
expressed on the cell surface (TLR1, -2, -4, -5 and -6) or retained intracellularly in endosomes 
(TLR3, -7, -8 and -9). Recent evidence also attested a major contribution of TLRs present at 
epithelial surfaces to antimicrobial defense and immunosurveillance (Weindl et al., 2007; de 
Luca et al., 2010). Distinct TLR ligands are able to mediate disparate effector responses through 
the same receptor, a phenomenon in part explained by the selective usage of adapter molecules 
such as myeloid differentiation factor 88 (MyD88) and Toll/IL-1 receptor (TIR) domain-
containing adapter inducing interferon-β (TRIF). Receptor engagement eventually culminates in 
the activation of transcription factors such as nuclear factor κB (NF-κB) and members of the 
interferon regulatory factor (IRF) family, which successively induce gene expression and 
production of various cytokines, chemokines and molecules required for antigen presentation or 
costimulation. 
The early finding that Toll-deficient Drosophila were unable to mount effective antifungal 
responses and were highly susceptible to infection by Aspergillus fumigatus highlighted a similar 
participation of mammalian TLRs in antifungal immunity. In fact, TLR2, -4 and -9 function has 
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5 
been categorically demonstrated to contribute to host responses against fungi both in mice and 
in humans (Cunha et al., 2010c). Given its crucial role in the immune response to fungi, TLR4 has 
been regarded as one major potential repository of genetic variability contributing to 
susceptibility to fungal diseases. For this reason, most studies performed to date have focused 
on the highly polymorphic TLR4 gene, in which two nonsynonymous polymorphisms – D299G 
and T399I – have been linked with blunted responses to inhaled lipopolysaccharide (Arbour et 
al., 2000). 
A donor haplotype in TLR4 consisting of the above-mentioned polymorphisms was 
disclosed as an independent predictive factor for IA among unrelated hematopoietic stem cell 
transplant (HSCT) recipients (Bochud et al., 2008). Although alternative explanations for this 
association have been proposed, namely the possible interaction of TLR4 with cytomegalovirus 
(CMV) (Cervera et al., 2009) or antifungal drugs (Levitz et al., 2009), the D299G and T399I 
polymorphisms have been linked with susceptibility to pulmonary aspergillosis in non-
transplanted patients, who are not susceptible to CMV disease and usually do not receive 
antifungal prophylaxis (Carvalho et al., 2008). In addition, we have reported an association of 
the TLR4 haplotype with fungal colonization following T-cell-depleted transplantation, although 
without increased risk for invasive disease (Carvalho et al., 2009). A previous study had also 
failed to associate TLR4 polymorphisms with IA in HSCT recipients, despite evidence pointing to 
a role of genetic variants in TLR1 and TLR6 (Kesh et al., 2005). These discrepancies between 
studies further stress that the contribution of genetic variants to IA may depend on several 
factors, such as the type of transplant and associated demographic and clinical co-variables. 
Uncovering the biological implications of TLR4 polymorphisms in the immune response to 
Aspergillus would ultimately strengthen the clinical repercussions of these findings. It is worth 
mentioning that polymorphisms in TLR2 and TLR9 were not associated with IA (Bochud et al., 
2008; Carvalho et al., 2009), although a common promoter polymorphism in TLR9 (-1237T>C) 
was shown to predispose to allergic bronchopulmonary aspergillosis (Carvalho et al., 2008). 
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6 
However, it also holds true that the absence of association should always be interpreted in the 
scope of the limited power of the existing studies. 
The TLR4 haplotype had also been suggested to contribute to a higher risk of Candida 
bloodstream infection (Van der Graaf et al., 2006). However, this underpowered report has been 
recently challenged by a study from the same group in a large cohort of patients with invasive 
candidiasis (IC), which excluded any role of these genetic variants in susceptibility to this 
disease (Plantinga et al., 2009a). Instead, polymorphisms in TLR1 were shown to be strong 
predictive markers for IC and functional assays demonstrated that the increased risk was 
associated with impaired production of cytokines such as IL-1β, IL-6 and IL-8. Although this 
provides proof of concept that TLR1 plays a major role in the pathogenesis of IC, it is of note that 
this study dealt only with nonsynonymous polymorphisms and thus, does not exclude additional 
genetic variability potentially impacting susceptibility to this disease. 
In addition, and despite no studies have revealed an association between genetic 
variants in TLR2 and candidiasis, the nonsynonymous polymorphism R753Q was shown to 
modulate cytokine release during Candida sepsis in intensive care unit patients (Woehrle et al., 
2008). The extent to which the deregulated cytokine production contributes to susceptibility to 
candidiasis is however still not clear. 
 
C-type lectin receptors (CLRs) 
Even though the signaling pathways elicited by TLRs are crucial for the control of fungal 
infection (Bellocchio et al., 2004), a pivotal role for dectin-1 as the prototype of innate non-TLR 
signaling pathway for antifungal sensing has been highlighted (Brown, 2006). Dectin-1 is a CLR 
that specifically recognizes the cell wall carbohydrate β-(1,3)-glucan of many fungi and mediates 
cell activation, cytokine production and a variety of antifungal responses either through the 
spleen tyrosine kinase Syk/cytoplasmic caspase recruiting domain 9 (CARD9) (LeibundGut-
Landmann et al., 2007) or Raf-1 (Gringhuis et al., 2009) pathways. 
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7 
Polymorphisms in the gene encoding for dectin-1 have also been recently addressed as 
potential predictive factors for the incidence of fungal diseases. In particular, the early stop 
codon polymorphism Y238X has been found to associate with recurrent mucocutaneous fungal 
infections (Ferwerda et al., 2009) and to contribute to Candida colonization after HSCT 
(Plantinga et al., 2009b). This susceptibility phenotype was correlated with the generation of a 
truncated dectin-1 protein unable to target the membrane, thereby restraining β-glucan binding 
by monocytes and resulting in defective cytokine production upon receptor engagement, in 
particular IL-17 (Ferwerda et al., 2009; Plantinga et al., 2009b). Interestingly, a similar 
susceptibility pattern to mucocutaneous infections related to a deficit in IL-17 production was 
also found in a family carrying loss-of-function mutations in CARD9 (Glocker et al., 2009), 
suggesting that disruption of dectin-1 signaling and concomitant failure to produce IL-17 in 
response to Candida critically impairs mucosal antifungal defense. Accordingly, the clinical 
manifestation of CMC was also recently found to rely on genetic defects in IL17F and IL17RA 
(Puel et al., 2011). 
Work from our group has also demonstrated that dectin-1 deficiency contributed as well 
to an increased susceptibility to IA following HSCT, an association which relied on either 
recipient or donor genetic make-ups and to be synergistically increased in polymorphic 
recipient/donor pairs (Cunha et al., 2010a).  Another study has instead proposed a limited 
influence of the Y238X polymorphism on susceptibility to IA, in particular in non-HSCT patients 
(Chai et al., 2011). This study however failed to address the likely confounding effects of 
population stratification on their conclusions given the enrollment of admixed heterogeneous 
patient populations. Larger, well-designed studies, preferably performed on consecutive 
patients, are ultimately required to clarify the role of the Y238X polymorphism in both HSCT and 
non-HSCT patients at risk of IA. 
Although dectin-1 has been regarded as one major innate receptor leading to T helper 17 
(Th17) activation in response to Aspergillus (Werner et al., 2009), production of IFN-γ and IL-10 
by dectin-1-deficient peripheral blood mononuclear cells, more than IL-17, was found to be 
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8 
impaired (Cunha et al., 2010a). Interestingly, polymorphic macrophages displayed instead 
adequate responses to the fungus (Chai et al., 2011). This suggests that pulmonary macrophages, 
in view of their role as primary line of defense, retain their ability to properly respond to 
Aspergillus ligands even in the absence of functional dectin-1, likely due to the inherent 
redundancy of the several PRRs (e.g. mannose receptor, TLR2, TLR4, etc.). Moreover, the 
contribution of recipient dectin-1 deficiency to the high risk of infection also reflects the crucial 
role of nonhematopoietic dectin-1 in the induction of immune protection to the fungus, 
highlighting the overlapping mechanisms of immune resistance and tolerance that are 
conditioned by the hematopoietic/nonhematopoietic compartmentalization. 
 
Other PRRs 
The collectin subfamily of lectins includes members such as mannose-binding lectin 
(MBL), pentraxin 3 (PTX3) and the lung surfactant proteins (SPs). Collectins are able to bind to 
fungi and activate the complement system leading to their opsonization or direct killing. Among 
this class of PRRs, MBL is the most extensively dissected member from a genetic point of view. A 
combination of structural and promoter polymorphisms is known to exist in the MBL2 gene and 
each may define the levels of functional protein (Garred, 2008). For this reason, since it was first 
reported, MBL deficiency has been consistently associated with increased susceptibility to 
infections, particularly when adaptive immunity is impaired. Accordingly, reduced levels of MBL 
have been recently correlated with the incidence of acute IA in non-HSCT immunocompromised 
patients, despite no causal nature was attributed to MBL polymorphisms (Lambourne et al., 
2009). Nevertheless, donor MBL2low genotypes (O/O or LXA/O) have been identified as 
important predictive factors of increased incidence of invasive fungal diseases after HSCT 
(Granell et al., 2006). Similarly, the nonsynonymous polymorphism D105G in recipient MBL-
associated serine protease 2 gene (MASP2), known to hinder MBL function, was also linked with 
invasive fungal disease after HSCT (Granell et al., 2006). However, the later finding deserves 
additional validation owing to the low number of recipients with the MASP2 variant. 
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9 
In addition to MBL, genetic mapping analysis of the survival data of an  
immunocompromised mice model has also allowed the identification of plasminogen, a 
regulatory molecule that binds to Aspergillus, as a suitable candidate gene for aspergillosis 
susceptibility (Zaas et al., 2008). The clinical translation of these findings acknowledged the 
nonsynonymous polymorphism D472N in the human gene encoding for plasminogen to 
influence the risk of developing IA in HSCT recipients, particularly late after transplantation. 
Besides shedding light into the role of the fibrinolytic system in the pathogenesis of IA, this 
computational approach identified a novel and biologically plausible candidate gene for 
susceptibility to IA, therefore validating its future use in the identification of less obvious fungal 
disease-related genes. 
 
Cytokines/chemokines 
Cytokines mediate the inflammatory and adaptive immune responses to pathogens. Whereas 
inflammation may serve to limit infection, when heightened, it may significantly contribute to 
pathogenicity, as documented by the elevated incidence of severe fungal infections in patients 
with immune reconstitution syndrome (Singh and Perfect, 2007). It is not surprising therefore 
that patients with inborn errors in the IL-12/IFN-γ axis, unable to mount proper inflammatory 
responses, are highly susceptible to disseminated fungal diseases such as 
paracoccidioidomycosis (PCM) (Moraes-Vasconcelos et al., 2005) and histoplasmosis (Zerbe and 
Holland, 2005). 
Genetic variants in cytokine genes have been considered crucial factors determining 
vulnerability to fungal infections, particularly aspergillosis. In this regard, IL-10 has been 
considered one major candidate for genetic studies as its production has been suggested to be 
largely genetically-determined, in part due to the promoter polymorphism -1082G>A. Indeed, 
patient IL10low genotypes were shown to confer protection from IA in both HSCT (Seo et al., 
2005) and non-HSCT (Sainz et al., 2007a) patients. Despite the fact that no actual correlation 
with serum levels was established in these studies, the validity of these associations is fairly 
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10 
reinforced by the finding that IL10high genotypes were instead linked with increased colonization 
with Aspergillus and allergic disease in patients with cystic fibrosis (Brouard et al., 2005). 
Similarly, increased production of IL-10 resulting from IL10high genotypes has also been shown 
to contribute to the development of chronic fungal infections such as PCM (Bozzi et al., 2006). 
Hence, and regardless of the lack of functional data definitely correlating IL10 polymorphisms 
with impaired immune responses to Aspergillus, the consistency of the associations based on 
genotype-defined IL-10 levels reflects the likely role of these polymorphisms in determining 
resistance versus susceptibility to aspergillosis. 
A small number of other studies have addressed the role of polymorphisms in additional 
cytokines and/or their receptors as predisposing factors to IA. For example, and despite analysis 
of individual locus failed to associate variants in the genes encoding for IL-1α, IL-1β and IL-1R 
antagonist (IL-1Ra) with IA, a polymorphism haplotype in this gene cluster (VNTR2/-889C/-
511T) was nevertheless strongly associated with susceptibility to this disease in hematological 
patients (Sainz et al., 2008). Work from the same group has also demonstrated a crucial 
contribution of polymorphisms in the TNF receptor 1 (TNFR1) and 2 (TNFR2) to an increased 
susceptibility to IA in non-HSCT patients (Sainz et al., 2007b; Sainz et al., 2010). In this case, and 
particularly regarding TNFR1, the observed susceptibility to IA was correlated with defective 
receptor expression, suggesting a crucial contribution of TNF-α signaling in the immune 
response to Aspergillus, at least in this particular setting of patients. 
In addition, we have found that the functional polymorphism R381Q affecting the 
receptor for IL-23 (IL-23R) instead conferred a protective effect regarding IA and correlated 
with improved survival of HSCT recipients (Carvalho et al., 2010a). Functionally, this specific 
polymorphism has been demonstrated to promote a deficient activation of IL-23-driven Th17 
responses (Cunha et al., 2010b). Interestingly, whereas committed effector Th17 cells derived 
from subjects harboring R381Q stimulated with IL-23 had an impaired production of IL-17, 
highly purified naïve T-cells did not, suggesting that the consequences of the polymorphism may 
be exclusively reflected in the function of differentiated Th17 cells. 
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11 
Recently, data has also pointed to the relevance of genetic variants in chemokine genes in 
host susceptibility to fungal diseases. A large-scale screening of polymorphisms led to the 
finding of a haplotype in CXC chemokine ligand 10 (CXCL10) resulting in increased susceptibility 
to IA in HSCT recipients (Mezger et al., 2008). Mechanistically, immature wild-type dendritic 
cells exposed to A. fumigatus showed a markedly increase in CXCL10 expression, in contrast to 
those harboring the risk haplotype. In this regard, it is also interesting to note that patients who 
survived IA had significantly higher CXCL10 levels in comparison to healthy controls. 
Altogether, and despite the need for replication studies in independent cohorts of 
patients, these findings point to the importance of maintaining a finely orchestrated balance 
between pro- and anti-inflammatory signals, fundamental for the immune system to effectively 
attack and eliminate pathogenic fungi, suggesting that the disruption of this equilibrium may 
ultimately underlie an increased predisposition to IA. 
 
Immunogenetics of invasive fungal diseases: what does the future hold? 
The dissection of the genetic bases underlying susceptibility to infectious diseases inspires a 
very active, yet complex, field of research. As the awareness of the individual genetic make-up 
may hold the key to expose unsuspected risk factors for these diseases, the current 
understanding of the immunological network involved in the immune response to pathogens 
needs to be addressed also from a genetic point of view. Given that the modulation of host 
immune responses has been regarded as a potential therapeutic target for the eradication of 
fungal diseases, knowing each individual’s immunogenetic profile, together with the application 
of promising therapeutic strategies such as siRNA delivery (Bonifazi et al., 2010),  could prove 
critical for the design of novel, effective fungal vaccines capable of targeting and exerting control 
over the outcome of specific signalling pathways. 
Although many of the studies published so far still lack replication, a step forward in this 
field would be provided by large-scale translational and clinical studies validating the data 
obtained from the genetic analyses. This would support the use of genetic screening of at-risk 
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patients and would ultimately allow the individualization of prophylaxis and treatments by 
means of targeted and patient-tailored approaches likely improving the management and 
outcome of these severe, often fatal diseases. 
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Figure legends 
Figure 1. Genetic polymorphisms of pattern recognition receptors (PRRs) and inflammatory 
mediators associated with susceptibility to invasive fungal diseases. 
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Figure 1. Genetic polymorphisms of pattern recognition receptors (PRRs) and inflammatory 
mediators associated with susceptibility to invasive fungal diseases.  
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